Cargando…

IL-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint

Mesenchymal stem cell-based therapy has great therapeutic potential for temporomandibular joint (TMJ) cartilage repair. However, the behavior of mesenchymal stem cells in the inflammatory milieu following their delivery remains poorly understood. Synovial fluid-derived mesenchymal stem cells (SFMSCs...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenjing, Sun, Yangpeng, He, Yiqing, Zhang, Hong, Zheng, Youhua, Yao, Yu, Zhang, Zhiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358692/
https://www.ncbi.nlm.nih.gov/pubmed/28000839
http://dx.doi.org/10.3892/ijmm.2016.2832
_version_ 1782516257914880000
author Liu, Wenjing
Sun, Yangpeng
He, Yiqing
Zhang, Hong
Zheng, Youhua
Yao, Yu
Zhang, Zhiguang
author_facet Liu, Wenjing
Sun, Yangpeng
He, Yiqing
Zhang, Hong
Zheng, Youhua
Yao, Yu
Zhang, Zhiguang
author_sort Liu, Wenjing
collection PubMed
description Mesenchymal stem cell-based therapy has great therapeutic potential for temporomandibular joint (TMJ) cartilage repair. However, the behavior of mesenchymal stem cells in the inflammatory milieu following their delivery remains poorly understood. Synovial fluid-derived mesenchymal stem cells (SFMSCs) are a promising resource for TMJ cartilage repair, as they are easily obtained from patients with TMJ disorders (TMD). In this study, we obtained SFMSCs from patients with TMD and expanded them in vitro; we then stimulated the cells with interleukin (IL)-8, IL-1β, IL-6, IL-10, tumor necrosis factor (TNF)-α and IL-12p. The cells expressed CD90, CD44, CD105 and CD73, and were negative for CD45, CD34, CD11b, CD19 and HLA-DR. They could be induced to differentiate into osteogenic, chondrogenic, adipogenic and neurogenic lineages in vitro. Only the levels of IL-6 and IL-8 were upregulated significantly following stimulation with IL-8, IL-1β, IL-6, IL-10, TNF-α and IL-12p. Furthermore, IL-6 and IL-8 expression was driven mainly by IL-1β-dependent nuclear factor-κB (NF-κB) pathway activation, and was independent of IL-8, IL-6, IL-10, TNF-α and IL-12p. IL-6 and IL-8 expression was inhibited completely by treatment with the NF-κB inhibitor, BAY11-7082. SRY-box 9 (SOX9) was downregulated and matrix metalloproteinase (MMP)13 was upregulated upon chondrogenic differentiation induced in the cells also exposed to IL-1β. Sulfated glycosaminoglycan production was also reduced upon chondrogenic differentiation in the presence of IL-6, but not IL-8. Thus, IL-1β in the inflammatory milieu is crucial in regulating SFMSCs. In doing so, IL-1β impedes the chondrogenic differentiation of SFMSCs. The upregulation of IL-6 and NF-κB pathway activation also contribute to this biological behavior. The findings of our study indicate the potential adverse effects of IL-1β on the chondrogenic differentiation of SFMSCs, and may thus provide new insight into the pathogenesis of TMD.
format Online
Article
Text
id pubmed-5358692
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-53586922017-04-06 IL-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint Liu, Wenjing Sun, Yangpeng He, Yiqing Zhang, Hong Zheng, Youhua Yao, Yu Zhang, Zhiguang Int J Mol Med Articles Mesenchymal stem cell-based therapy has great therapeutic potential for temporomandibular joint (TMJ) cartilage repair. However, the behavior of mesenchymal stem cells in the inflammatory milieu following their delivery remains poorly understood. Synovial fluid-derived mesenchymal stem cells (SFMSCs) are a promising resource for TMJ cartilage repair, as they are easily obtained from patients with TMJ disorders (TMD). In this study, we obtained SFMSCs from patients with TMD and expanded them in vitro; we then stimulated the cells with interleukin (IL)-8, IL-1β, IL-6, IL-10, tumor necrosis factor (TNF)-α and IL-12p. The cells expressed CD90, CD44, CD105 and CD73, and were negative for CD45, CD34, CD11b, CD19 and HLA-DR. They could be induced to differentiate into osteogenic, chondrogenic, adipogenic and neurogenic lineages in vitro. Only the levels of IL-6 and IL-8 were upregulated significantly following stimulation with IL-8, IL-1β, IL-6, IL-10, TNF-α and IL-12p. Furthermore, IL-6 and IL-8 expression was driven mainly by IL-1β-dependent nuclear factor-κB (NF-κB) pathway activation, and was independent of IL-8, IL-6, IL-10, TNF-α and IL-12p. IL-6 and IL-8 expression was inhibited completely by treatment with the NF-κB inhibitor, BAY11-7082. SRY-box 9 (SOX9) was downregulated and matrix metalloproteinase (MMP)13 was upregulated upon chondrogenic differentiation induced in the cells also exposed to IL-1β. Sulfated glycosaminoglycan production was also reduced upon chondrogenic differentiation in the presence of IL-6, but not IL-8. Thus, IL-1β in the inflammatory milieu is crucial in regulating SFMSCs. In doing so, IL-1β impedes the chondrogenic differentiation of SFMSCs. The upregulation of IL-6 and NF-κB pathway activation also contribute to this biological behavior. The findings of our study indicate the potential adverse effects of IL-1β on the chondrogenic differentiation of SFMSCs, and may thus provide new insight into the pathogenesis of TMD. D.A. Spandidos 2017-02 2016-12-15 /pmc/articles/PMC5358692/ /pubmed/28000839 http://dx.doi.org/10.3892/ijmm.2016.2832 Text en Copyright: © Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Liu, Wenjing
Sun, Yangpeng
He, Yiqing
Zhang, Hong
Zheng, Youhua
Yao, Yu
Zhang, Zhiguang
IL-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint
title IL-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint
title_full IL-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint
title_fullStr IL-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint
title_full_unstemmed IL-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint
title_short IL-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint
title_sort il-1β impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358692/
https://www.ncbi.nlm.nih.gov/pubmed/28000839
http://dx.doi.org/10.3892/ijmm.2016.2832
work_keys_str_mv AT liuwenjing il1bimpedesthechondrogenicdifferentiationofsynovialfluidmesenchymalstemcellsinthehumantemporomandibularjoint
AT sunyangpeng il1bimpedesthechondrogenicdifferentiationofsynovialfluidmesenchymalstemcellsinthehumantemporomandibularjoint
AT heyiqing il1bimpedesthechondrogenicdifferentiationofsynovialfluidmesenchymalstemcellsinthehumantemporomandibularjoint
AT zhanghong il1bimpedesthechondrogenicdifferentiationofsynovialfluidmesenchymalstemcellsinthehumantemporomandibularjoint
AT zhengyouhua il1bimpedesthechondrogenicdifferentiationofsynovialfluidmesenchymalstemcellsinthehumantemporomandibularjoint
AT yaoyu il1bimpedesthechondrogenicdifferentiationofsynovialfluidmesenchymalstemcellsinthehumantemporomandibularjoint
AT zhangzhiguang il1bimpedesthechondrogenicdifferentiationofsynovialfluidmesenchymalstemcellsinthehumantemporomandibularjoint